Roundup Deal: Plaintiffs Raise Concerns; Judge Casts Doubt

  • Roundup Deal: Plaintiffs Raise Concerns; Judge Casts Doubt

On Thursday, U.S. District Judge Vince Chhabria, overseeing the Roundup multidistrict litigation docket, indicated that he might lift the stay on litigation after hearing concerns from plaintiffs' attorneys over the uncertainty of the more than $10 billion deal.

In June, the German chemical and pharmaceutical giant, Bayer, indicated that it would pay more than $10 billion to settle about 75% of the lawsuits claiming that its herbicide Roundup was the cause of non-Hodgkin’s lymphoma. Following the announcement of the deal, which is managed by mediator Kenneth Feinberg, Judge Chhabria halted the multidistrict litigation for the settlement process.

In July, Judge Chhabria had raised concerns over one part of the deal, which includes a plan for handling future claims brought by the consumers who develop non-Hodgkin’s lymphoma, after using the weedkiller. He indicated that he is skeptical of the propriety and fairness of the proposed settlement, and is tentatively inclined to deny the motion.

In the recent hearing, Judge Chhabria stated that he received several confidential letters alleging the manufacturer of reneging on its deal with the plaintiffs. After hearing arguments from both parties, he concluded that he would not lift the stay expressing his confidence in Feinberg’s ability to reach a resolution in 30 days. But he also noted that the parties should also start reworking on getting the litigation back on track as he won't extend the stay any further. The parties have been asked to be prepared by the next case management conference that is scheduled for September 24.

Roundup, one of the most commonly and widely used weedkillers, contains Glyphosate as one of its main ingredients. Glyphosate is a systemic and broad-spectrum herbicide that was patented by a U.S. company, Monsanto, in 1970. Bayer acquired Monsanto on June 7, 2018.

Currently, Bayer is facing more than 125,000 Roundup lawsuits, and the company has acknowledged the filing of 52,500 lawsuits. The lawsuits are consolidated under MDL No. 2741 in the U.S. District Court for the Northern District of California.

We are social:



NSIC-CRISIL has assigned a "SE 2A" rating to Neural IT, indicating a company with High Performanc...

ISO 27001 Certification

Neural IT is officially ISO 27001:2013 (ISO 27001) certified by Alcumus ISOQAR Limited as the Cer...


Neural IT has successfully implemented HIPAA for securing Health records....



NYSTLA - "Neural IT is proud to be associated with NYSTLA (New York State Trial Lawyers Associati...


CAOC - "Neural IT is proud to be associated with CAOC (Consumer Attorneys of California) as a Ven...


CAALA - "Neural IT is proud to be associated with CAALA (Consumer Attorneys Association of Los An...

News & Events

Friends Of CAALA 2020
It is a treasured moment for Neural IT to be associated as an Affiliate Member for so many years and receive an…
Amidst the chaos of COVID-19 pandemic, we have something to cheer about as today is National Smile Day, and a smile is…
Happy Mother's Day from Neural IT
The cagey pandemic has halted our lives, but the only spirits that kept igniting during the crisis are the ones whom we…

Latest Tweets